Showing results (1791-1800 of 2,609) with videos related to

Sort By:
Pageof 261
Oncology Research|January 30, 2026
A Holistic Review of Oncological Drug Targets and Trajectories of Resistance in Cancer TherapyHarpreet Kaur, Dhrubalochan Rana, Sowvik Bag, et al.
Oncology Research|January 30, 2026
Targeting Sphingolipids in Breast Cancer: From Tumor Biology to Therapeutic StrategiesMin Hee Kim, Boyoon Huh, Joo-Won Park, et al.
Oncology Research|January 30, 2026
PIK3R1 as a Gastric Cancer Biomarker Linked to CD73 + Treg-Mediated ImmunosuppressionBu Zou, Yi-En Xu, Hui-Chan He, et al.
Oncology Research|January 8, 2026
Application Value and Research Frontiers of Immunotherapy in Glioblastoma: A Bibliometric and Visualized AnalysisKun Deng, Jianliang Huang, Danyang Li, et al.
Oncology Research|January 8, 2026
Biological Features of KLC2 Mutations in Chronic Myeloid Leukemia and Their Contribution to Inducing Drug ResistanceRabindranath Bera, Yotaro Ochi, Ying-Jung Huang, et al.
Oncology Research|January 8, 2026
PNP as a Metabolic and Prognostic Driver of Breast Cancer Aggressiveness: Insights from Patient Tissue and Cell ModelsSarra B Shakartalla, Iman M Talaat, Nival Ali, et al.
Oncology Research|January 8, 2026
Pan-Cancer Analysis of Enhancer-Induced PAN3-AS1 and Experimental Validation as a WFDC13-Promoting Factor in Colon CancerXu Guo, Yanan Yu, Xiaolin Ma, et al.
Oncology Research|January 8, 2026
HE4 Might Participate in Extracellular Matrix Remodeling in Ovarian Cancer via Activation of FibroblastsYimin Liu, Bin Liu, Huabin Gao, et al.
Oncology Research|December 30, 2024
Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapyEnrico Caliman, Sara Fancelli, Federico Scolari, et al.
Oncology Research|December 30, 2024
HNRNPC as a pan-cancer biomarker and therapeutic target involved in tumor progression and immune regulationYuezhou Zhang, Zhao Zhang, Jinxin Dong, et al.
Pageof 261